Skip Navigation
Skip to contents

JLC : Journal of Liver Cancer

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > J Liver Cancer > Volume 8(1); 2008 > Article
Case Report A Case of Advanced Hepatocellular Carcinoma Successfully Treated by Repeated Transcatheter Arterial Chemoembolization, Percutaneous Ethanol Injection and Surgical Resection
Jaejun Shim1, Byung-Ho Kim1, Jae Young Jang1, Seok Ho Dong1, Hyo Jong Kim1, Young Woon Chang1, Rin Chang1, Sung Hwa Hong2, Joo Hyeong Oh3
Journal of Liver Cancer 2008;8(1):120-123
DOI: https://doi.org/
Published online: June 30, 2008
1Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Korea
2Department of General Surgery, Kyung Hee University School of Medicine, Seoul, Korea
3Department of Radiology, Kyung Hee University School of Medicine, Seoul, Korea
Corresponding author:  Byung-Ho Kim,
Email: kimbh@khu.ac.kr
  • 497 Views
  • 0 Download
  • 0 Crossref
  • 0 Scopus

Here we report a case of multifocal advanced hapatocellular carcinoma successfully treated by repeated transc atheter arterial chemoembolization (TACE), percutaneous ethanol injection (PEI) and surgical resection. Previously healthy 54-year old man was admitted for the evaluation of incidental hepatic masses. Abdominal CT revealed multifocal hepatic masses in right lobe including segment 5, 6 and 8, which showed early wash-out pattern in portal phase and increased serum alpha fetoprotein (>840 ng/mL) was compatible with advanced hepatocelluar carcinoma (stage III). Underlying cirrhosis was noted and Child-Pugh classification was A (5 points). After 4 cycles of TACE, nodular masses in segment 6 and 8 were completely lipiodolized. Viable mass in the remained huge mass in right anterior lobe was treated by surgical resection. After 4 month operation, abdominal CT revealed new hepatoma lesion at right anterior lobe, serum AFP was increased to 61 ng/mL. The lesion was treated by one session of TACE. Underlying chonic hepatitis C was also treated with interferon and ribavirin. The patient has been followed for 9 years without evidence of regional tumor recurrence or distant metastasis.


JLC : Journal of Liver Cancer